Skip to main content
SpringerLink
Log in

Serum levels of GH, IGF-I, LH and ovarian steroids in cyclic and RU486-treated rats

  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Rats lacking progesterone action due to RU486 treatment have been reported to show numerous endocrine and morphological similarities with respect to human polycystic ovary syndrome (PCO). Nevertheless, abnormalities on insulin or insulin-like growth factor I (IGF-I) production, a frequent finding in the polycystic disease, have not been studied in such rats yet. The aim of these experiments was to evaluate the serum concentrations of IGF-I in rats treated with 4 mg of the antiprogestagen RU486 over 4 or 8 consecutive days starting on estrus (day 1) and decapitated on the morning of day 5 and 9. Serum levels of growth hormone (GH), luteinizing hormone (LH), testosterone (T) and 17β estradiol (E2) were determined and correlated with those of IGF-I. Controls were rats injected with oil and killed in the morning of metestrus, diestrus, proestrus and estrus. Rats treated with RU486 had increased serum concentrations of IGF-I, LH, T and E2 with respect to control rats on estrus, while no differences were found in the serum concentrations of GH. Parallel estrous cycle related changes were observed in the serum concentrations of IGF-I, T and E2 with the highest values at proestrus. However, changes on serum concentrations of GH were not associated with those of IGF-I in control rats through the estrous cycle. The present results are consistent with the idea that beside on GH, serum concentrations of IGF-I in the rat depend also on LH or LH-dependent ovarian steroid production. Moreover, the results indicate that IGF-I production increased in RU486-treated rats, which may have a role in the ovarian abnornalities induced by RU486 treatment in the rat.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Sánchez-Criado J.E., Sánchez A., Ruiz A., Gaytán F. Endocrine and morphological features of cystic ovarian condition in antiprogesterone RU486-treated rats. Acta Endocrinol. (Copenh.) 129: 237, 1993a.

    Google Scholar 

  2. Sánchez-Criado J.E., Galiot F., Bellido C., González D., Tébar M. Hypothalamus-pituitary-ovarian axis in cyclic rats lacking progesterone actions. Biol. Reprod. 48: 916, 1993b.

    Article  PubMed  Google Scholar 

  3. Ruiz A., Aguilar R., Tébar M., Gaytán F., Sánchez-Criado J.E. RU486-treated rats show analogous endocrine and morphological responses to women with polycystic ovary syndrome treated with similar therapies. Biol. Reprod. 55: 1284, 1996.

    Article  PubMed  CAS  Google Scholar 

  4. Yen S.S.C. The polycystic ovarian syndrome. Clin. Endocrinol. (Oxf.) 12: 177, 1980.

    Article  CAS  Google Scholar 

  5. Barnes R., Rosenfield R.L. The polycystic ovarian syndrome: pathogenesis and treatment. Ann. Intern. Med. 110: 386, 1989.

    Article  PubMed  CAS  Google Scholar 

  6. Dunaif A., Graf M., Mandeli J., Laumas V., Drobrjansky A. Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia. J. Clin. Endocrinol. Metab. 65: 499, 1987.

    Article  PubMed  CAS  Google Scholar 

  7. Schuller A.G.P., Lindenberghkortleve D.J., Pache D.T., Zwarthoff E.C., Fauser B.C.J.M., Drop S.L.S. Insulin-like growth binding protein 2, 28-kDa and 24-kDa insulin-like growth factor binding protein levels are decreased in fluid of dominant follicles, obtained from normal and polycystic ovaries. Regul. Pept. 48: 157, 1993.

    Article  PubMed  CAS  Google Scholar 

  8. Iwashita M., Mimuro T., Watanabe M., Setoyama T., Matsuo A., Adachi T., Takeda Y., Sakamoto S. Plasma levels of insulin-growth factor I and its binding protein in polycystic ovary syndrome. Horm. Res. 33: 21, 1990.

    Article  PubMed  CAS  Google Scholar 

  9. Allen W.R., Nilsen-Hamilton M., Hamilton R.T. Insulin and growth factors stimulate rapid post-trans-lational changes in glucose transport in ovarian granulosa cells. J. Cell. Physiol. 198: 15, 1981.

    Article  Google Scholar 

  10. Hsueh A.J.W., Adashi E.Y., Jones P.B., Welsh T.H. Jr. Hormonal regulation of the differentiation of cultured ovarian granulosa cells. Endocr. Rev. 5: 76, 1984.

    Article  PubMed  CAS  Google Scholar 

  11. Adashi E.Y., Resnick C.E., D’Ercole E.J., Svodoba M.E., Van Wyk J.J. Insulin-like growth factors as intraovarian regulators of granulosa cell growth and function. Endocr. Rev. 6: 400, 1985.

    Article  PubMed  CAS  Google Scholar 

  12. Babieri R.L., Makris A., Randall R.W., Daniels G., Kistner R.W., Ryan K.J. Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism. J. Clin. Endocrinol. Metab. 62: 904, 1986.

    Article  Google Scholar 

  13. Cara J.F., Rosenfield R.L. Insulin and insulin-like growth factor I potentiate luteinizing hormone-induced androgen synthesis by rat ovarian theca-interstitial cells. Endocrinology 123: 733, 1988.

    Article  PubMed  CAS  Google Scholar 

  14. Giudice L.C. Insulin-like growth factors and ovarian follicular development. Endocr. Rev. 13: 641, 1992.

    PubMed  CAS  Google Scholar 

  15. Van Wyk J.J., Underwood L.E., Hntz R.L., Clemmons D.R., Voina S.J., Weaver R.P. The somatomedins: a family of insulin-like hormones under growth hormone control. Recent Prog. Horm. Res. 30: 259, 1974.

    PubMed  Google Scholar 

  16. Hsu C.J., Hammond J.M. Gonadotropins and estradiol stimulate immunoreac-tive insulin-like growth factor-l production by porcine granulosa cells in vitro. Endocrinology 120: 198, 1987.

    Article  PubMed  CAS  Google Scholar 

  17. Hernandez E.R., Roberts C.T., LeRoith D., Adashi E.Y. Rat ovarian insulin-like growth factor I (IGF-I) gene expression is granulosa cellselective: 5′-untranslated mRNA variant representation and hormonal regulation. Endocrinology 125: 572, 1989.

    Article  PubMed  CAS  Google Scholar 

  18. Baulieu E.E. Contragestion and other clinical application of RU486, an antiprogestagen at the receptor. Science 245: 1351, 1989.

    Article  PubMed  CAS  Google Scholar 

  19. Baulieu E.E. The antisteroid RU486. Its cellular and molecular mode of action. TEM 2: 233, 1991.

    PubMed  CAS  Google Scholar 

  20. Sánchez-Criado J.E., Bellido C., Galiot F., López F., Gaytán F. A possible dual mechanism of the anovulatory action of antiprogesterone RU486 in the rat. Biol. Reprod. 42: 877, 1990.

    Article  PubMed  Google Scholar 

  21. Greenwood P.C., Hunter W.M., Glover J.S. The preparation of 131-labeled human growth hormone of high specific radioactivity. Biochem. J. 89: 114, 1963.

    PubMed Central  PubMed  CAS  Google Scholar 

  22. Hermanussen M., Rol de Lama M., Romero A.P., Ariznavarreta C., Burmeister J.A., Tresguerres J.A.F. Differential catch-up in body weight and bone growth after short term starvation in rats. Growth Regul. 6: 230, 1996.

    PubMed  CAS  Google Scholar 

  23. Valid measurements of total IGF concentrations in biological fluids. Recommendations from the 3rd international symposium on Insulin-like Growth Factors. Endocrinology 136: 816, 1995.

  24. Crawford B.A., Martin J.L., Howe C.J., Handelsman D.J., Daxter R.C. Comparision of extraction methods for insulin-like growth factor-l in rat serum. J. Endocrinol. 134: 169, 1992.

    Article  PubMed  CAS  Google Scholar 

  25. Daughaday W.H., Mariz I.K., Blethen L. Inhibition of access of bound somatomedin to membrane receptor and immunobinding sites: a comparison of radioreceptor and radioimmnunoassay of somatomedin in native and acid-ethanol-extracted serum. J. Clin. Endocrinol. Metab. 51: 781, 1980.

    Article  PubMed  CAS  Google Scholar 

  26. Sánchez-Criado J.E., Tébar M., Sánchez A., Gaytán F. Evidence that androgens are involved in atresia and anovulation induced by antiprogesterone RU486 in rats. J. Reprod. Fertil. 99: 173, 1993c.

    Article  PubMed  Google Scholar 

  27. Sánchez-Criado J.E., Uilenbroek JThJ, de Jong F.H. Antiprogesterone RU486 increases serum im-munoreactive inhibin levels and LH: FSH and testosterone: oestradiol ratios in cyclic rats. J. Endocrinol. 134: 51, 1992.

    Article  PubMed  Google Scholar 

  28. Murphy L.J., Bell G.I., Friesen H.G. Tissue distribution of insulin-like growth factor I and II messenger ribonucleic acid in the adult rat. Endocrinology 120: 1279, 1987.

    Article  PubMed  CAS  Google Scholar 

  29. Whitley N.C., Barb C.R., Utley R.V., Popwell J.M., Kraeling R.R., Rampacek G.B. Influence of stage of the estrous cycle on insulin-like growth factor-l modulation of luteinizing hormone secretion in the gilt. Biol. Reprod. 53: 1359, 1995.

    Article  PubMed  CAS  Google Scholar 

  30. Smith M.S., Freeman M.E., Neil J.D. The control of progesterone secretion during the estrous cycle and early pseudopregnancy in the rat: prolactin, gonadotropin, and steroid levels associated with the rescue of the corpus luteum of pseudo-pregnancy. Endocrinology 96: 219, 1975.

    Article  PubMed  CAS  Google Scholar 

  31. Hammond J.M., Kinght A.P., Rechler M.M. Somatomedin secretion by porcine granulosa cells: a potential mechanism for regulating ovarian follicular growth. Clin. Res. 32: 485, 1984a.

    Google Scholar 

  32. Hammond J.M., Baranao J.L.F., Skaleris D.A., Rechler M.M., Knight A.P. Somatomedin (Sm) production by cultured porcine granulosa cells (GC). J. Steroid Biochem. 20: 1597, 1984b.

    Article  Google Scholar 

  33. Aguilar E., Pinilla L. Ovarian role in the modulation of pituitary responsiveness to growth hormone-releasing hormone in rats. Neuroendocrinology 54: 286, 1991.

    Article  PubMed  CAS  Google Scholar 

  34. Roberts CT., Brown A.L., Graham D.E., Seelig S., Berry S., Gabbay K.H., Rechler M.M. Growth hormone regulates the abundance of insulinlike growth I RNA in adult rat liver. J. Biol. Chem. 261: 10025, 1986.

    PubMed  CAS  Google Scholar 

  35. Hynes M.A., Van Wyk J.J., Brooks P.J., D’Ercole A.J., Jansen J., Lund P.K. Growth hormone dependence of somatomedin-C/in-sulin-like growth factor I and insulin-like growth factor II messenger ribonucleic acids. Mol. Endocrinol. 1: 233, 1987.

    Article  PubMed  CAS  Google Scholar 

  36. Berga S.L., Mortola J.F., Girton L., Suh B., Laughlin G., Pham P., Yen S.S.C. Neuroendocrine aberrations in women with functional hypothalamic amenorrhea. J. Clin. Endocrinol. Metab. 66: 301, 1989.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Physiology, Faculty of Medicine, University of Córdoba, Avda. Menéndez Pidal s/n, 14004, Córdoba, Spain

    A. Ruiz, M. Tébar & J. E. Sánchez-Criado

  2. Complutense of Madrid, Madrid, Spain

    A. Pérez-Romero & M. A. Rol de Lama

Authors
  1. A. Ruiz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Tébar
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Pérez-Romero
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. A. Rol de Lama
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J. E. Sánchez-Criado
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ruiz, A., Tébar, M., Pérez-Romero, A. et al. Serum levels of GH, IGF-I, LH and ovarian steroids in cyclic and RU486-treated rats. J Endocrinol Invest 20, 611–615 (1997). https://doi.org/10.1007/BF03346918

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03346918

Key-words

Search

Navigation